Costs and Consequences from the Achois Randomized Trial of Treatment of Mild Gestational Diabetes Mellitus
Year: 2007
Type: preprint
Abstract: Objective To appraise the costs and consequences of treating women with mild gestational diabetes mellitus by dietary advice, blood glucose monitoring and insulin therapy as needed compared with routine pregnancy care. Design Cost-consequences analysis using patient-level data from within a multi-centre randomized clinical trial. Setting Obstetric and neonatal units in 18 hospitals in Australia (predominantly) and England. Population Women with a singleton pregnancy who had mild gestational diabetes diagnosed by an oral glucose-tolerance test between 24 and 34 weeks' gestation and their infants. Method Clinical outcomes and outpatient costs derived from all 970 women with a singleton pregnancy and their infants in the trial. Inpatient costs from women and infants attending the hospital contributing the largest number of enrolments, 26.1%. Costs to women and their families from a subsample of participants from that hospital. Costs are in 2002 Australian dollars. Main Outcome Measures Primary clinical outcomes were serious perinatal complications (defined prospectively as one or more of the following: death, shoulder dystocia, bone fracture, and nerve palsy); admission to a neonatal nursery; jaundice requiring phototherapy; induction of labour and caesarean delivery. Economic outcome measures were outpatient and inpatient costs, and costs to women and their families. Results Over the course of the ACHOIS trial, for every 100 women with a singleton pregnancy and a positive OGTT who were offered treatment for mild gestational diabetes mellitus (by dietary advice, blood glucose monitoring and insulin therapy as needed) in addition to routine obstetric care, $53,985 additional direct costs were incurred at the obstetric hospital, $6,521 additional costs were incurred by the women and their families, 9.7 additional women experienced an induction of labour, and 8.6 more babies were admitted to a neonatal nursery, yet 2.2 fewer babies experienced any serious perinatal complication (includes perinatal death, shoulder dystocia, bone fracture, and nerve palsy), and 1.0 fewer babies experienced a perinatal death. The incremental cost per additional serious perinatal complication prevented was thus $27,503. The incremental cost per perinatal death prevented was $60,506. The incremental cost per discounted life-year gained was $2,988. Discussion Although a cost-consequences analysis was planned because trading-off between the utilities of mother and infant would entail difficult conceptual and ethical issues, the actual trial results enabled the estimation of a credible cost-effectiveness ratio. Conclusions Treatment in this way of women with a singleton pregnancy who have gestational diabetes resulted in a reduction in serious perinatal complications, although more women experienced an induction of labour, and more infants were admitted to the neonatal nursery. There was no material increase in the direct inpatient costs, but there was an increase in the antenatal outpatient costs and the direct out-of-pocket costs. [[It is likely that the general public in high-income countries such as Australia would find the reductions in perinatal mortality and in serious perinatal complications sufficient to justify the additional health service and personal monetary costs.]] Taking a perspective over the whole lifespan, the incremental cost per extra life-year gained is highly favourable. Trial Registration Number: ACTRN012606000294550. This paper is presented on behalf of the Australian Carbohydrate Intolerance in Pregnant Women (ACHOIS) Trial Group.
Source: SSRN Electronic Journal
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Keywords: gestational diabetes mellitus, cost-consequence analysis, dietary recommendations, blood glucose monitoring, insulin therapy, perinatal complications, perinatal death, labor induction, cesarean section, shoulder dystocia, neonatal jaundice, cost-effectiveness, family costs, life-years gained
Open Access status: green
OpenAlex ID: W2272786309
